header
Image from OpenLibrary

Targeted therapy for hematological maliganacies / Mona Shafik Mahmoud Elashry ; Supervised Omaima Abdelkader Gohar , Ghada Ibrahim Mossallam

By: Contributor(s): Language: Eng Publication details: Cairo : Mona Shafik Mahmoud Elashry , 2008Description: 231Leaves : charts , facsimiles ; 25cmOther title:
  • العلاجات الاستهدافية فى سرطان الدم [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Clinical and Chemical Pathology Summary: Leukemias and lymphome are relatively common , affect all ages and demonstrate extra - ordinary biologic , morphologic and clinical heterogenrcity.Immunotherapy , mainly antibody - based therapy in non - hodgkin's lymphomas , has become one of the success stories of targeted therapy today especiallyrituximab which is in broad clinical use all over the world
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2008.Mo.T (Browse shelf(Opens below)) Not for loan 01010110049770000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2008.Mo.T (Browse shelf(Opens below)) 49770.CD Not for loan 01020110049770000

Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Clinical and Chemical Pathology

Leukemias and lymphome are relatively common , affect all ages and demonstrate extra - ordinary biologic , morphologic and clinical heterogenrcity.Immunotherapy , mainly antibody - based therapy in non - hodgkin's lymphomas , has become one of the success stories of targeted therapy today especiallyrituximab which is in broad clinical use all over the world

Issued also as CD

There are no comments on this title.

to post a comment.